The Trump administration reportedly expressed confidence in Elon Musk’s commitment to Tesla, stating ‘Elon’s not going anywhere.’ This sentiment comes amid discussions about Musk’s potential role in midterm […]
Empty Ports, Empty Shelves: Trump’s Tariff Battle Set to Hit Home Soon
The ongoing tariff battle initiated by the Trump administration is beginning to show its effects on the U.S. economy. Reports indicate that ports are seeing fewer imports and […]
Elon Musk’s Popularity Declines Rapidly, New Poll Reveals
A recent poll conducted by the Associated Press in collaboration with the NORC Center for Public Affairs Research indicates that Elon Musk’s popularity is rapidly declining. As of […]
Georgia Big Lots Locations Set to Reopen in May
Big Lots is set to reopen six locations in Georgia in May, following the company’s emergence from Chapter 11 bankruptcy protection and its acquisition by Variety Wholesalers. This […]
Tech Stocks Lead Market Decline Amid Trade War Uncertainty
NEW YORK (AP) — U.S. stocks experienced a downturn on Monday, reversing some of their recent gains, as investors brace for potential market volatility later in the week. […]
Access to Website Blocked Due to Automation Tools
Access to this page has been restricted because we suspect you are using automation tools to browse the website. This issue might arise if: Javascript is disabled or […]
Key Consumer Protections at Risk Amid Legal Battles
As President Donald Trump’s administration continues its cost-cutting measures, the Consumer Financial Protection Bureau (CFPB) faces significant challenges. Many of its regulations are now under scrutiny. In February, […]
FDA’s New Requirements for Novavax Vaccine Raise Concerns About Future Approvals
The FDA’s request for Novavax to conduct a new clinical trial before granting full approval for its COVID-19 vaccine has sparked uncertainty regarding updates to other vaccines. Novavax […]
CG Oncology Stock Surges Amid Promising Cancer Treatment Results
Shares of CG Oncology (CGON) surged to a four-month high following the release of promising results for its bladder cancer treatment, which rivals Johnson & Johnson’s (JNJ) offering. […]
Merck KGaA to Acquire Rare Cancer Biotech SpringWorks for $3.9B
Merck KGaA has announced plans to acquire SpringWorks, a biotech company specializing in treatments for rare cancers, in a deal valued at $3.9 billion. This acquisition aims to […]